Running Title: Inflammatory/stress pathway activity in skeletal muscle in obesity and hyperlipidemia. 
INTRODUCTION
Recently, it has been proposed that elevated activity of pro-inflammatory/stress signaling pathways play an important role in the pathogenesis of insulin resistance in obesity, and perhaps type II diabetes. This hypothesis is supported by the observations that obesity and type II diabetes are states of chronic, low-grade inflammation (9, 12, 35) , that increased expression of pro-inflammatory factors such as TNF-α (13, 26, 27 ) and IL-6 (21) decrease insulin sensitivity, and more recent studies demonstrating that decreased activity of pro-inflammatory/stress signaling pathways improves, or prevents the development of insulin resistance (1, 5, 14, 17, 20, 32, 38) .
Cell responses to inflammatory and stress signals are mediated by a number of ubiquitously expressed signaling cascades. Of these, the IKK/IκB/NFκB and mitogen activated protein kinase (MAPK) pathways, specifically c-Jun N-terminal kinase (JNK) and p38 MAPK, are best described. Altered activity of each of these pathways has been implicated in changing insulin action. Thus, reduced IKK/IκB/NFκB activity (1, 5, 17, 20, 32, 38) prevents the development of lipid-induced and/or obesity-induced insulin resistance in cells (32) and in rodents (1, 5, 20, 38) and improves insulin sensitivity in T2DM (17) . Increased activity of IKK/IκB/NFκB in mouse skeletal muscle induces dramatic tissue wastage, but insulin action appears to be unaltered (4), while increased IKK/IκB/NFκB activity in liver (5) results in the development of insulin resistance. JNK deficient mice are partially resistant to the development of insulin resistance resulting from a high fat diet (14) while basal p38 MAPK phosphorylation is increased and responsiveness to insulin is lost (22) in skeletal muscle in T2DM. Finally, studies in mouse skeletal muscle and L6 myotubes suggests that increased activity of p38 MAPK may be a negative regulator of glucose uptake (15) . Despite these observations, the effects of obesity on the activity of proinflammatory/stress pathways in skeletal muscle, the major insulin-sensitive tissue by mass in the body, remain unclear. Furthermore, the mechanisms of activation of proinflammatory/stress pathways in obesity are poorly understood. The current study was undertaken to address each of these issues. Specifically, we determined the effects of DIO and acute hyperlipidemia on levels of IκBα and p38 MAPK phosphorylation (commonly used indicators of activity of NFκB and p38 MAPK, respectively) and JNK activity in three skeletal muscles differing in fiber-type composition and insulin sensitivity. The data demonstrate that DIO and acute hyperlipidemia (HL) decrease skeletal muscle IκBα, and that the effects of DIO and HL on IκBα levels are skeletal muscle fiber-type dependent. Furthermore, HL, but not DIO, decreases p38 MAPK activity in a fiber-type dependent manner. However, DIO and HL have no effect on skeletal muscle JNK activity. Obesity Studies. A 4-6 week high fat diet is sufficient to induce obesity and insulin resistance in rats (3, 16, 29, 33, 34 ). In the current study, 6 week high fat fed animals and standard chow fed control animals were fasted overnight (18h), anesthetized with pentobarbital and three skeletal muscles differing in fiber-type [superficial vastus, fast twitch-glycolytic; soleus, slow twitch-oxidative, and gastrocnemius, mixed fast twitchglycolytic and slow twitch-oxidative] were extracted and flash frozen in liquid nitrogen.
MATERIALS AND METHODS

Animal
Tissues were stored at -70 o C until analysis.
Lipid Infusion Studies. Approximately 8 days prior to the study, catheters were inserted into the carotid artery and the contralateral jugular vein as described previously (7, 28, 30) . When animals had recovered to >90% of pre-surgery weight, they were fasted overnight. The following day, the indwelling cannulas were cleared with saline and extended with silastic tubing after which the animals were infused with Liposyn Plasma Measurements. Plasma triglycerides were measured using the GPO-triglyceride kit (Sigma, Atlanta, GA) with Lintrol lipids as standards (Sigma, Atlanta, GA). Plasma free fatty acids were measured using the free fatty acid, half-micro test kit (Roche Diagnostics, Penzberg, Germany).
Statistics. All results are expressed as means ± se. Statistical significance was determined by unpaired t-test using the Systat statistical programme (Evanston, IL).
Significance was assumed at P < 0.05.
RESULTS
Skeletal muscle IκBα levels are decreased by DIO in a fiber-type dependent manner.
In previous studies we (3, 16) and others (29, 33, 34) have demonstrated in rats that a 4-6 week high fat diet is sufficient to induce obesity and insulin resistance. Thus, we first determined the effects of diet-induced obesity (DIO) on levels of skeletal muscle IκBα, a commonly used indicator of activity of the IKK/IκB/NFκB pathway (24) . Body weight, adiposity, and plasma FFA and triglyceride concentrations were increased in DIO compared to standard chow fed (LEAN) controls (Table 1 ). In superficial vastus (VAS), a muscle composed predominantly of fast twitch, glycolytic fibers, IκBα levels were decreased by 24±3% (P=0.001) in DIO compared to LEAN ( Figure 1 ). Interestingly, these decreases did not occur in soleus (SOL), a slow-twitch, oxidative fiber type muscle, or in gastrocnemius (GAS), a mixed fiber-type muscle ( Figure 1 ). Thus, decreases in IκBα levels induced by DIO in skeletal muscle are fiber-type dependent.
Acute hyperlipidemia reproduces the effects of DIO on IκBα levels in skeletal muscle.
Dysregulated lipid metabolism and hyperlipidemia is commonly associated with obesity and has been implicated in the pathogenesis of insulin resistance (2, 19, 25, 36) .
Furthermore, lipids activate IKK/IκB/NFκB in macrophages (23), endothelial cells (8), and L6 rat myotubes (32) . Thus, hyperlipidemia is one possible mechanism mediating decreased skeletal muscle IκBα levels in DIO. To address this hypothesis in the absence of other confounding metabolic abnormalities of obesity, acute hyperlipidemia was induced in lean animals by an infusion of liposyn II for 6h. As previously reported (37), this intervention increased plasma FFA levels by ~20-fold ( saline, n=6 in each group). Similar to DIO, IκBα levels were decreased in VAS (26±5%, P=0.006) in lipid-infused compared to saline-infused animals, but were unaltered in SOL, (Figure 2 ). However, unlike DIO, IκBα levels were also decreased in GAS (15±4%, Similar to IKK/IκB/NFκB, altered JNK and p38 MAPK activity has been implicated in mediating alterations in insulin action (6, 14, 15, 22) . Thus, we next determined the effects of DIO and acute hyperlipidemia on activity of these two pathways in skeletal muscle. DIO did not alter the activity of JNK or p38 MAPK in any of the skeletal muscles examined (Figures 4 and 5) . Acute hyperlipidemia decreased p38 MAPK phosphorylation in VAS, but not in SOL or GAS, and had no effect on JNK activity.
JNK activity was not measured in SOL because of lack of tissue.
DISCUSSION
The primary goal of the current study was to determine the effects of DIO in rats on the activity of inflammatory/stress pathways in skeletal muscle and to begin to address possible mechanisms responsible for activation of these pathways. The rationale for this study was recent observations implicating altered activity of pro-inflammatory/stress pathways, specifically IKK/IκB/NFκB, JNK, and p38 MAPK in altering insulin action.
A number of novel observations arise from our studies. We demonstrate that (1) DIO is associated with decreased levels of the NFκB inhibitor IκBα in skeletal muscle; (2) the effects of DIO are fiber-type dependent, since IκBα levels were decreased in fast, glycolytic fibers, but not in slow, oxidative fibers; (3) acute hyperlipidemia reduces skeletal muscle IκBα levels, suggesting one mechanism for the effects of DIO; (4) differential accumulation of skeletal muscle triglycerides do not correlate with the fibertype dependent effects of DIO and acute hyperlipidemia on IkBα levels, and (5) DIO has no effect on p38 MAPK or JNK activity in rat skeletal muscle.
The current study demonstrates that both DIO and acute hyperlipidemia result in decreased levels of skeletal muscle IκBα, a situation that is normally associated with increased NFκB activity. These data are in good agreement with a previous observation in humans of decreased skeletal muscle IκBα levels in response to an acute lipid infusion (18) . Recent studies have demonstrated that inhibition of the IKK/IκB/NFκB pathway by salicylates, an IKK inhibitor, decreases skeletal muscle insulin resistance associated with a high fat diet (38) , acute hyperlipidemia (20) , and type II diabetes (17) . Direct evidence for a role for increased IKK/IκB/NFκB activity in the pathogenesis of skeletal muscle insulin resistance is more varied. One group reports in mice that a deficiency of IKK activity, and hence NFκB activity, protects against the development of insulin resistance on a high fat diet (38) or in response to a lipid infusion (20) , but a more recent study failed to reproduce the effects of a high fat diet (31) . The reasons for these discrepant findings are unclear. Constitutively active skeletal muscle IKK activity in mouse induces severe muscle wastage but insulin sensitivity is unaltered (4). However, it is unclear how insulin sensitivity was determined in this study or if the potentially confounding variable of muscle wastage influenced insulin action in these animals. In the context of the current study, we can state that IKK/IκB/NFκB activation is associated with the development of skeletal muscle insulin resistance in two independent rat models (current study and 20). Furthermore, previous studies in L6 rat myotubes demonstrate that activation of IKK/IκB/NFκB by fatty acids induces insulin resistance, and that blocking of NFκB activation is sufficient to prevent lipid-induced insulin resistance (32).
However, given the studies discussed above it cannot be stated at this time that NFκB activation in skeletal muscle is required for the development of insulin resistance in vivo.
An important conclusion arising from our study is that the effects of DIO and acute hyperlipidemia on the levels of IκBα in skeletal muscle is fiber-type dependent.
Skeletal muscle fibers-types can be characterized based on differences in their oxidative capacity and insulin sensitivity. Thus, slow twitch fibers have a high oxidative capacity, and are very insulin sensitive. Conversely, fast twitch fibers have a lower oxidative capacity and insulin sensitivity. IκBα levels were decreased in DIO in superficial vastus, but not in gastrocnemius or soleus muscle. Relatively similar results were obtained with acute hyperlipidemia, although unlike DIO, IκBα levels were also decreased in gastrocnemius. In humans acute hyperlipidemia activates IKK/IκB/NFκB in a mixed fiber-type muscle (vastus), confirming that our observations are not restricted to rodents.
Perhaps the most unexpected observation was that IKK/IκB/NFκB was not activated in soleus muscle, the most insulin sensitive muscle examined, by DIO or acute hyperlipidemia. Previous studies (3, 37) Finally, there is a substantial body of work supporting a role for lipids in the pathogenesis of insulin resistance (2, 19, 36) . However, it should be noted that a number of proinflammatory factors that are elevated in obesity are also capable of activating IKK/IκB/NFκB, suggesting that activation of this pathway may be mediated by a number of mechanisms in obesity.
It has been proposed that accumulation of lipids within tissues may be a mechanism of activation of inflammatory pathways. In the current study, triglyceride levels were increased in both soleus and superficial vastus muscles in DIO compared to lean controls, whereas IκBα levels were only reduced in the superficial vastus. The effects of acute hyperlipidemia were somewhat more complex. Thus, as previously A somewhat surprising observation in the current study is that the activity of JNK and p38 MAPK were for the most part unaltered by DIO or acute hyperlipidemia in the three muscles examined. A previous study (14) in mice demonstrated increased JNK activity in skeletal muscle of DIO mice compared to lean mice, while increased basal activity of p38 MAPK has been reported in skeletal muscle in type II diabetes (6, 22) .
The reason for the differences between our current observations and those from other studies are unclear. In the case of JNK, one can propose species difference (rats vs. mice), but given the close phylogenetic relationship of the two species, this is a somewhat unsatisfactory explanation. In the case of p38 MAPK, it is more likely that the species differences do play a role, in addition to the fact that type II diabetes is a potentially confounding variable.
In conclusion, the current study demonstrates that both DIO and acute hyperlipidemia decrease skeletal muscle IκBα levels in a fiber-type dependent manner.
Since the effects of DIO and acute hyperlipidemia are similar we speculate that dyslipidemia may be a mechanism for activation of inflammatory/stress pathways in obesity and type II diabetes. Subsequently, triglyceride levels were measured as described in Materials and Methods.
Results are presented as mean±se. n=a minimum of six animals for the two muscles.
Significant differences are indicated. 
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